
Project Alive Urges FDA to Prioritize Approvals for Life-Saving Rare Disease Treatments Fof RGX-121 Gene Therapy
CRESTLINE, CA, UNITED STATES, August 22, 2025 /EINPresswire.com/ -- Project Alive, a leading nonprofit dedicated to advocating for children and families impacted by Hunter syndrome (MPS II), is calling on the U.S. Food and Drug Administration (FDA) to …